Investment Management Corp of Ontario

Position in GILD — Gilead Sciences, Inc.

CIK 1811568 Toronto, Z4

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$10,410,542

-$2,712,676 QoQ

Shares Held

82,401

-12.5% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#423

of 2,266 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Investment Management Corp of Ontario holds $290,694,409 across 9 Drug Manufacturers - General names. GILD ranks #8 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	77,551	$93,017,003
2	JNJ	Johnson & Johnson	236,219	$59,992,539
3	ABBV	AbbVie Inc.	180,178	$45,339,991
4	MRK	Merck & Co., Inc.	276,725	$35,559,162
5	PFE	Pfizer Inc	763,834	$18,393,122
6	AMGN	Amgen Inc	36,725	$13,298,857
7	BMY	Bristol Myers Squibb Co	219,828	$12,666,489
8	GILD	Gilead Sciences, Inc. This page	82,401	$10,410,542

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,410,542	82,401	-12.5%	Shares	Sole	2026-08-14
2026-03-31	$13,123,218	94,161	-12.3%	Shares	Sole	2026-05-15
2025-12-31	$13,178,102	107,366	+60.9%	Shares	Sole	2026-02-17
2025-09-30	$7,408,584	66,744	-63.3%	Shares	Sole	2025-11-14
2025-06-30	$20,159,159	181,827	-11.1%	Shares	Sole	2025-08-14
2025-03-31	$22,929,127	204,633	+42.1%	Shares	Sole	2025-05-15
2024-09-30	$12,076,984	144,048	+43.1%	Shares	Sole	2024-11-14
2024-06-30	$6,907,586	100,679	+8.3%	Shares	Sole	2024-08-14
2024-03-31	$6,810,711	92,979	-68.0%	Shares	Sole	2024-05-15
2023-12-31	$23,547,338	290,672	+89.5%	Shares	Sole	2024-02-14
2023-09-30	$11,494,522	153,383	+30.8%	Shares	Sole	2023-11-14
2023-06-30	$9,039,771	117,293	+4.6%	Shares	Sole	2023-08-14
2023-03-31	$9,301,517	112,107	+98.8%	Shares	Sole	2023-05-15
2022-12-31	$4,841,339	56,393	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.